|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Predictors of readmission in colon cancer were ASA class (odds ratio (OR) 4.5), TNM (OR for TNM III 3.24, TNM IV 4.55), evidence of residual tumor (R2) (OR 3.96), and medical (OR 1.96) and infectious (OR 2.01) complications within 30 days after surgery, while for rectal cancer, the predictors identified were age (OR 1.03), R2 (OR 6.48), infectious complications within 30 days (OR 2.29), hemoglobin (OR 3.26), lymph node ratio (OR 2.35), and surgical complications within 1 month (OR 3.04).
|
31485982 |
2020 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
In the univariate analysis the factors associated with SSI-CRAN were ASA score > 2 (48.4% vs. 35.5% in SSI-CRAN and no SSI-CRAN respectively, <i>p</i> = 0.025), extrinsic tumour (28.6% vs. 19.2%, <i>p</i> = 0.05), and re-intervention (4.4% vs. 1.4%, <i>p</i> = < 0.001).
|
31073400 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In multivariable analysis, sex (p = 0.004), body mass index (BMI) (p < 0.001), ASA score (p = 0.039), preoperative albumin (p = 0.035), pancreatic duct diameter (p = 0.002), and location of tumor (p < 0.001) were identified as independent predictors for POPF.
|
30982739 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Patient characteristics were well balanced between groups: mean age was 64.9 years (SD 15.9), BMI was 26.3 (SD 5.7), 38.1% of patients had ASA ≥ 3, and 78.3% underwent surgery for neoplasms.
|
31646437 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The pre-operative performance status, ASA grade, lung function, risk factors, surgical approach and tumour histology were similar between the groups.
|
30409440 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Preoperative CEA levels were associated with age, BMI, ASA and tumour stage.
|
30822523 |
2019 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Preoperative Risk Stratification in Spine Tumor Surgery - A Comparison of the Modified Charlson Index, Frailty Index, and ASA Score.
|
30601357 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, the combination of conventional chemotherapy with ASA may offer a new strategy to counteract tumor malignancy.
|
30144594 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In conclusion, distinct platelet-dependent mechanisms inhibited by ASA+Cl treatment promoted cancer malignancy and VM in the presence of primary tumour and afforded protection against pulmonary metastasis in the absence of primary tumour.
|
29707148 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The group of patients over 80 years of age had a significantly higher ASA physical status classification (P < 0.001), more preoperative comorbidities (P < 0.001), had a tendency towards more tumors in a colonic location (P = 0.034), and more advanced American Joint Committee on Cancer TNM stage (P = 0.001).
|
28580347 |
2017 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Univariate analysis identified ASA (P < 0.001), tumor grade (P = 0.009) and margin status (P = 0.042) as prognostic factors associated with survival.
|
27751529 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
After adjustment for covariates on multivariable analysis, race (p = .01), ASA (p = .02), CKD (p < .01), tumor size (p = .02), and tumor complexity (p = .03) still predicted poor discharge quality.
|
27671904 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
There was statistical association between overall survival and ASA (p=0.047), tumor stage (p=0.003), lymph node involvement (p=0.024), presence of metastases (p=0.013), level of tumor thrombus (p=0, 05) and histological type (p=0.001).
|
27461850 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The analysis included the following variables: patient-related variables (gender, age, diabetes mellitus, ASA score, preoperative radiochemotherapy, body mass index, blood hemoglobin, and serum albumin level), tumor-related variables (K-ras status, distance of tumor from the anal verge, histopathologic grade, pathological T stage, pathological N stage, pathological M stage, TNM stage, and tumor size), and surgery-related variables (laparoscopic or open surgery, blood loss, and operative time).
|
28766076 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Iron deficiency was significantly associated with an increased postoperative complication rate (univariable OR 1.94, p = 0.03, multivariable OR 1.84, p = 0.07), with right-sided tumours (p < 0.001), high ASA classification (p = 0.002), advanced tumour stage (p = 0.01) and advanced age (p = 0.04).
|
28889320 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A matched-pair analysis was performed on the basis of sex, age, BMI, ASA classification and tumor stage.
|
28550435 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
It is possible that the low penetration of ASA-404 into the brain prevents concentrations sufficient enough reaching the tumor in order to exhibit acute effects <i>in vivo</i>.
|
29098034 |
2017 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
5-ASA increases replication fidelity in mononucleotide, dinucleotide, and tetranucleotide repeats and reduces mutations in tumor suppressor genes TGFBR2 and ACVR2, a finding that may provoke in vivo studies for the prevention of colorectal cancer in hereditary nonpolyposis colorectal cancer.
|
20197483 |
2010 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we have examined genetically defined MMR-deficient murine embryo fibroblasts, murine colonocytes, and isogenic human HNPCC tumor cell lines treated with acetylsalicylic acid (aspirin; ASA) and three isomeric derivatives of NO-aspirin (NO-ASA).
|
18006842 |
2007 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The activities of arylsulfatase A and B from transplanted carcinomas with four histological types were more than twofold higher as compared to those from surgical tumors, except for arylsulfatase A activity in blastoma.
|
6114860 |
1981 |